1. Agreement between factor XIII activity and antigen assays in measurement of factor XIII: A French multicenter study of 147 human plasma samples. (20th March 2017) Authors: Caron, C.; Meley, R.; Le Cam Duchez, V.; Aillaud, M. F.; Lavenu‐Bombled, C.; Dutrillaux, F.; Flaujac, C.; Ryman, A.; Ternisien, C.; Lasne, D.; Galinat, H.; Pouplard, C. Journal: International journal of laboratory hematology Issue: Volume 39:Number 3(2017:Jun.) Page Start: 279 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Efficacy of rituximab in acquired factor XIII inhibitor after arterial rFVIIa‐induced thrombosis. (4th December 2012) Authors: Ngo Sack, F.; Galinat, H.; Egreteau, P.‐Y.; Mollard, L. M.; Fortin, H.; Berthou, C.; Abgrall, J. F.; Pan‐Petesch, B. Journal: Haemophilia Issue: Volume 19:Number 2(2013:Mar.) Page Start: e93 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗